Correlation between clinical response to antiandrogenic therapy and occurrence of receptors in human prostatic cancer.
Occurrence of steroid hormone receptor has been evaluated in 30 prostatic cancer-bearing patients: 5 alpha-dihydrotestosterone receptor (DHTR) occurrence was correlated with both tumor grade of differentiation and clinical response to hormone therapy.
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D003534:Cyproterone / Q000627:therapeutic use*; D013196:Dihydrotestosterone / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011374:Progesterone / Q000378:metabolism; D011467:Prostate / Q000032:analysis*; D011470:Prostatic Hyperplasia / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011987:Receptors, Steroid / Q000032:analysis*
D000726:Androgen Antagonists; D011987:Receptors, Steroid; D013196:Dihydrotestosterone; D011374:Progesterone; D004958:Estradiol; D003534:Cyproterone; D006854:Hydrocortisone